Skip to main content

Table 4 Provision of information for type of main product discussed

From: Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia

Information   New medicine   Old medicine with new information/indication   Old medicine with general information  
Type of product   Australia
n/9 (%)
Malaysia
n/41 (%)
Australia
n/18 (%)
Malaysia
n/54 (%)
Australia
n/31 (%)
Malaysia
n/30 (%)
Indications Yes 8 (89) 39 (96) 17 (94) 49 (91) 27 (87) 28 (93)
  No 1(11) 1(2) 1 (6) 4 (7) 4 (13) 2 (7)
  Unsure 0 1(2) 0 1 (2) 0 0
     ^*P = 0.72    
     &*P = 0.56    
Dosage Yes 7 (78) 35 (85) 14 (78) 45 (83) 23 (74) 23 (77)
  No 2 (22) 6 (15) 4 (22) 9 (17) 8 (26) 7 (23)
     ^P = 0.95    
     &P = 0.62    
Contraindications Yes 5 (55) 24 (59) 4 (22) 20 (37) 10 (32) 6 (20)
  No 3 (33) 17 (41) 13 (72) 32 (59) 21 (68) 23 (77)
  Unsure 1 (12) 0 1 (6) 2 (4) 0 1 (3)
     ^*P = 0.15    
     &*P = 0.01    
Precautions Yes 4 (45) 17 (41) 5 (28) 14 (26) 12 (39) 7 (23)
  No 4 (45) 23 (57) 12 (66) 38 (70) 18 (58) 21 (70)
  Unsure 1 (12) 1 (2) 1 (6) 2 (4) 1 (3) 2 (7)
     ^*P = 0.59    
     &*P = 0.19    
Drug interactions Yes 5 (55) 16 (39) 3 (16) 11 (20) 11 (35) 4 (13)
  No 4 (45) 23 (56) 14 (78) 41 (76) 20 (65) 25 (84)
  Unsure 0 2 (5) 1 (6) 2 (4) 0 1 (3)
     ^*P = 0.14    
     &*P = 0.02    
Adverse effects Yes 6 (67) 23 (57) 7 (39) 16 (30) 11 (35) 6 (20)
  No 3 (33) 17 (41) 11 (61) 34 (63) 19 (62) 22 (73)
  Unsure 0 1 (2) 0 4 (7) 1 (3) 2 (7)
     ^*P = 0.26    
     &*P = 0.01    
  1. *Chi square test for questions that included variable "unsure" was calculated based on categorical variables "Yes" and "No" only.
  2. ^ P-value (Comparison between type of products: Australia)
  3. & P-value (Comparison between type of products: Malaysia)